#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)June 11 - 14, 2026

 

 #### Stockholm, Sweden

 

 

 

Visit Novartis **Booth #E2.10** (accessible only to registered attendees)

**Additional resources**

- [EHA2026 homepage](https://ehaweb.org/connect-network/eha2026-congress)
- [Explore the program](https://ehaweb.org/connect-network/eha2026-congress/eha2026-program)



 



##  Latest news 

 [Jun 01, 2026

- Press release

 

###  Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

 ](/news/media-releases/scemblix-continued-show-superior-efficacy-and-favorable-safety-and-tolerability-profile-week-144-newly-diagnosed-cml) [May 21, 2026

- Press release

 

###  Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

 ](/news/media-releases/novartis-advances-rlt-innovation-and-reinforces-leadership-prostate-cancer-breast-cancer-and-hematology-new-data-asco-and-eha) 





 

 [View more news](/news/news-archive?type=media_release "View more news")